ARK ETF TR - GENOMIC REV ETF (ARKG)

Historical Holders from Q4 2014 to Q4 2025

Type / Class: Equity / GENOMIC REV ETF
Symbol: ARKG
Price per share: $28.97
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 22,091,981
Total reported value: $613,262,276
% of total 13F portfolios: 0%
Share change: +699,150
Value change: +$21,888,378
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 227

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025, ARK ETF TR - GENOMIC REV ETF (ARKG) has 227 institutional shareholders filing 13F forms. They hold 22,091,981 shares. .

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	176,954	$5,230,328	+$2,697,687			2,897.07%	8
2025 Q3	22,091,981	$613,262,276	+$21,888,378	$77,034,162	$64,265,200	2,777%	227
2025 Q2	21,611,541	$526,299,881	-$30,340,397	$106,621,580	$95,858,360	2,435%	208
2025 Q1	23,101,944	$479,673,052	-$55,581,608	$79,651,193	$96,541,347	2,076%	208
2024 Q4	24,350,767	$573,698,426	-$37,898,474	$58,275,400	$68,187,338	2,354.5%	232
2024 Q3	27,310,972	$699,040,899	+$92,400,865	$67,331,483	$75,124,351	2,560%	236
2024 Q2	22,680,631	$532,966,671	+$39,117,310	$153,622,596	$65,208,656	2,348%	258
2024 Q1	21,051,021	$605,315,066	+$15,377,386	$80,761,356	$42,222,556	2,876%	278
2023 Q4	40,048	$1,313,957	-$111,418			3,280.94%	4
2023 Q3	14,964,987	$416,338,753	-$84,578,287	$28,400,484	$28,213,822	2,786%	272
2023 Q2	19,271,641	$656,715,949	-$80,554,434	$22,095,139	$26,262,667	3,409%	278
2023 Q1	22,219,219	$667,988,176	+$78,019,849	$73,816,772	$26,015,924	3,007%	283
2022 Q4	18,495,002	$522,412,596	-$45,263,425	$32,145,995	$44,283,934	2,823%	303
2022 Q3	21,729,001	$714,027,536	+$12,249,016	$48,050,000	$67,928,013	3,286.93%	285
2022 Q2	19,742,778	$624,094,591	-$149,933,659	$51,747,000	$58,439,012	3,149%	307
2022 Q1	22,990,194	$1,055,473,346	+$47,100,819	$240,205,066	$177,637,066	4,593%	351
2021 Q4	22,686,543	$1,387,496,635	-$127,764,585	$445,087,000	$153,957,336	6,123.99%	436
2021 Q3	23,358,292	$1,745,083,472	-$179,706,452	$361,009,000	$194,687,000	7,471.9%	458
2021 Q2	25,647,114	$2,368,838,906	+$45,767,495	$809,271,000	$452,952,500	9,250%	503
2021 Q1	25,103,980	$2,227,839,504	+$476,694,908	$1,068,270,112	$460,965,900	8,873%	492
2020 Q4	19,523,924	$1,824,936,990	+$621,552,740	$405,650,000	$189,904,000	9,326.02%	401
2020 Q3	11,577,010	$738,525,015	+$163,889,690	$991,000	$2,235,000	6,371%	232
2020 Q2	9,009,545	$470,488,716	+$198,153,792			5,215.97%	158
2020 Q1	5,270,783	$164,882,371	+$40,942,551			3,128.03%	92
2019 Q4	4,087,582	$137,034,456	+$26,009,516			3,351.91%	83
2019 Q3	3,319,801	$98,044,241	+$10,573,112			2,951.94%	73
2019 Q2	2,944,101	$101,464,963	+$13,071,408			3,446.67%	65
2019 Q1	2,580,144	$84,845,609	+$18,848,967			3,287.91%	60
2018 Q4	2,056,805	$50,001,695	+$5,584,128			2,398.01%	54
2018 Q3	1,930,241	$64,524,505	+$26,870,620			3,342.76%	54
2018 Q2	1,153,856	$33,505,295	+$11,408,048			2,906.11%	43
2018 Q1	770,723	$19,841,482	+$11,638,696			2,574.76%	38
2017 Q4	318,853	$7,834,898	+$1,265,719			2,449.18%	16
2017 Q3	264,822	$6,957,723	+$2,355,607			2,624.03%	12
2017 Q2	26	$1,000	-$316,000			3,846.15%	1
2017 Q1	33,397	$689,000	-$16,347			2,069.22%	4
2016 Q4	34,527	$586,000	+$32,517			1,700.88%	5
2016 Q3	32,597	$648,000	-$411,758			1,989.48%	5
2016 Q2	53,282	$897,000	+$82,555			1,678.71%	4
2016 Q1	48,349	$848,000	+$343,310			1,754.43%	5
2015 Q4	28,783	$603,000	+$219,908			2,095.46%	3
2015 Q3	18,282	$343,000	-$327,900			1,876.16%	1
2015 Q2	35,623	$821,000	+$190,002			2,304.86%	3
2015 Q1	27,374	$623,000	-$292,145			2,268.71%	2
2014 Q4	40,223	$854,000	+$800,999			2,121.69%	2